October 16, 2012 — Proteon Therapeutics Inc. has initiated enrollment in a Phase 1 clinical study of its lead product ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
October 4, 2012 — This year’s European Society of Cardiology (ESC) Congress in Munich, Germany, was a stark example of ...
October 04, 2012
October 2, 2012 — A novel blood thinner recently approved by the U.S. Food and Drug Administration (FDA), Pradaxa ...
October 02, 2012
October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA ...
October 01, 2012
September 25, 2012 — Men and women who undergo joint replacement procedures, as well as those who have significant ...
September 25, 2012September 13, 2012 — Janssen Research & Development LLC announced that it has submitted the complete response to the U.S ...
September 13, 2012
Feature | Nicole Fornell, Pharm D
A major issue with clopidogrel is that one-third of patients are nonresponders because they lack the enzymes to ...
August 28, 2012
Feature | Antiplatelet and Anticoagulation Therapies | Nicole Fornell, Pharm D
The standard-of-care for dual antiplatelet therapy (DAPT) for more than a decade has been clopidogrel (Plavix) plus ...
August 28, 2012August 23, 2012 — Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, finds that ...
August 23, 2012
August 9, 2012 — The Harvard Clinical Research Institute (HCRI) announced today the successful completion of ...
August 09, 2012July 27, 2012 — Major safety fears over supraventricular tachycardia (SVT) medications are threatening many elderly ...
July 27, 2012July 26, 2012 — Transgenomic Inc. has announced that National Government Services, the designated Medicare fiscal ...
July 26, 2012July 26, 2012 — Angion Biomedica Corp. announced that the first patient was dosed in a Phase II multicenter clinical ...
July 26, 2012July 25, 2012 — Grady Memorial Hospital has standardized and improved patient education and reduced by 75 percent the ...
July 25, 2012July 20, 2012 — Ticagrelor (Brilinta), a blood-thinning drug approved by the U.S. Food and Drug Administration (FDA) in ...
July 20, 2012